What does CUSIP 90400D108 represent in this 13F holders report?

CUSIP 90400D108 is the security identifier for RARE - Ultragenyx Pharmaceutical Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held RARE - Ultragenyx Pharmaceutical Inc. - Common Stock in Q1 2016?

159 institutional investors reported RARE - Ultragenyx Pharmaceutical Inc. - Common Stock for Q1 2016. Use the holders table for investor-level position and value details.

Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)

CUSIP: 90400D108

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Stock
Shares outstanding: 98,367,418
Total 13F shares: 37,365,438
Share change: +1,792,113
Total reported value: $2,365,011,412
Put/Call ratio: 105%
Price per share: $63.31
Number of holders: 159
Value change: +$86,675,812
Number of buys: 89
Number of sells: 77

Quarterly Holders Quick Answers

What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016
Previous quarter: Q4 2015

Recent filing periods for CUSIP 90400D108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	5.9%	5,822,942	$653,217,000	—	31 Dec 2015	13F
Capital Research Global Investors	13F	Company	4.8%	4,756,473	$533,581,000	—	31 Dec 2015	13F
VANGUARD GROUP INC	13F	Company	2.4%	2,393,587	$268,512,000	—	31 Dec 2015	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.3%	2,297,234	$257,703,000	—	31 Dec 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.8%	1,774,736	$199,090,000	—	31 Dec 2015	13F
BlackRock Fund Advisors	13F	Company	1.4%	1,419,462	$159,235,000	—	31 Dec 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.4%	1,351,387	$151,599,000	—	31 Dec 2015	13F
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F	Company	1.1%	1,111,566	$124,695,000	—	31 Dec 2015	13F
STATE STREET CORP	13F	Company	1%	983,423	$110,321,000	—	31 Dec 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.91%	891,338	$99,990,000	—	31 Dec 2015	13F
JENNISON ASSOCIATES LLC	13F	Company	0.77%	755,388	$84,739,000	—	31 Dec 2015	13F
Visium Asset Management, LP	13F	Company	0.64%	629,934	$70,665,000	—	31 Dec 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	0.57%	560,394	$62,865,000	—	31 Dec 2015	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.48%	470,331	$52,762,000	—	31 Dec 2015	13F
NORTHERN TRUST CORP	13F	Company	0.44%	428,973	$48,122,000	—	31 Dec 2015	13F
FEDERATED HERMES, INC.	13F	Company	0.41%	399,800	$44,850,000	—	31 Dec 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.4%	396,598	$44,491,000	—	31 Dec 2015	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.39%	386,101	$43,313,000	—	31 Dec 2015	13F
RS INVESTMENT MANAGEMENT CO LLC	13F	Company	0.39%	384,223	$43,102,000	—	31 Dec 2015	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.37%	362,516	$40,667,000	—	31 Dec 2015	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.34%	333,500	$37,412,000	—	31 Dec 2015	13F
OppenheimerFunds, Inc.	13F	Company	0.32%	310,949	$34,882,000	—	31 Dec 2015	13F
NORGES BANK	13F	Company	0.31%	306,589	$34,393,000	—	31 Dec 2015	13F
ROCKEFELLER FINANCIAL SERVICES INC	13F	Company	0.29%	289,907	$32,521,000	—	31 Dec 2015	13F
LORD, ABBETT & CO. LLC	13F	Company	0.28%	279,713	$31,378,000	—	31 Dec 2015	13F
AXA S.A.	13F	Company	0.25%	249,948	$28,039,000	—	31 Dec 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.25%	247,726	$27,789,000	—	31 Dec 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.25%	242,668	$27,221,000	—	31 Dec 2015	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.24%	236,010	$26,476,000	—	31 Dec 2015	13F
BlackRock Group LTD	13F	Company	0.22%	217,763	$24,428,000	—	31 Dec 2015	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.22%	211,924	$23,773,000	—	31 Dec 2015	13F
Polar Capital LLP	13F	Company	0.21%	210,000	$23,558,000	—	31 Dec 2015	13F
WEATHERBIE CAPITAL, LLC	13F	Company	0.21%	206,559	$23,172,000	—	31 Dec 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.2%	194,190	$21,784,000	—	31 Dec 2015	13F
Bank of New York Mellon Corp	13F	Company	0.18%	176,336	$19,781,000	—	31 Dec 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.17%	167,869	$18,832,000	—	31 Dec 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.17%	165,526	$18,565,000	—	31 Dec 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.16%	159,052	$17,842,000	—	31 Dec 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	153,788	$17,252,000	—	31 Dec 2015	13F
Allianz Asset Management GmbH	13F	Company	0.15%	148,190	$16,681,000	—	31 Dec 2015	13F
TEACHERS ADVISORS, LLC	13F	Company	0.14%	136,198	$15,279,000	—	31 Dec 2015	13F
BAKER BROS. ADVISORS LP	13F	Company	0.13%	123,894	$13,898,000	—	31 Dec 2015	13F
Iguana Healthcare Management, LLC	13F	Company	0.12%	115,000	$12,901,000	—	31 Dec 2015	13F
BROWN ADVISORY INC	13F	Company	0.12%	114,122	$12,803,000	—	31 Dec 2015	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.11%	110,004	$12,340,000	—	31 Dec 2015	13F
Opaleye Management Inc.	13F	Company	0.11%	110,000	$12,340,000	—	31 Dec 2015	13F
Cormorant Asset Management, LP	13F	Company	0.11%	109,500	$12,284,000	—	31 Dec 2015	13F
Rock Springs Capital Management LP	13F	Company	0.11%	105,500	$11,835,000	—	31 Dec 2015	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.09%	91,586	$10,274,000	—	31 Dec 2015	13F
Tekla Capital Management LLC	13F	Company	0.09%	88,400	$9,917,000	—	31 Dec 2015	13F

Institutional Holders of Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) as of Q1 2016

As of 31 Mar 2016, Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) was held by 159 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,365,438 shares. The largest 10 holders included FMR LLC, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, BlackRock Fund Advisors, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, COLUMBIA WANGER ASSET MANAGEMENT LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 159 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders

165

Q1 2016 holders

159

Holder diff

-6

Investor	Q4 2015 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2015 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.